Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013

H.R. 1325 S. 323, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" regarding all provisions. H.R. 1416, "Cancer Patient Protection Act of 2013," regarding all provisions. H.R. 351 and S. 351, "Protecting Seniors' Access to Medicare Act of 2013," regarding all provisions. H.R. 2010 and S. 1821, SGR Reform, regarding all provisions. H.R. 4301, Protecting Access to Medicare act, regarding all provisions.

Client expense: Not reported · Firm income: $770,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

S. 323/H.R. 1428 to extend immunosuppressive drug coverage beyond the current three year cap; Encourage Congress to open Medicare Advantage to dialysis patients; H.R. 4814 to improve kidney disease research and treatment; and Refinement of Star Ratings for Dialysis Facility Compare.

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

P.L. 111-148/P.L. 111-152, Affordable Care Act, Health care reform in general. HR 1428/S.323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. No Bill #, legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages, HR 5263 Living Donor Protection Act.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1325 S. 323, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" regarding all provisions. H.R. 1416, "Cancer Patient Protection Act of 2013," regarding all provisions. H.R. 351 and S. 351, "Protecting Seniors' Access to Medicare Act of 2013," regarding all provisions. H.R. 2010 and S. 1821, SGR Reform, regarding all provisions.H.R. 4301, Protecting Access to Medicare act, regarding all provisions.

Client expense: $680,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R.1074/S.539 - National Diabetes Clinical Care Commission Act S.323/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013 S. 2689/H.R. 5644 - Medicare CGM Access Act of 2014

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 1428/S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages, HR 5263 Living Donor Protection Act

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1325 S. 323, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" regarding all provsions. H.R. 1416, "Cancer Patient Protection Act of 2013," regarding all provisions. H.R. 351 and S. 351, "Protecting Seniors' Access to Medicare Act of 2013," regarding all provisions. H.R. 2010 an dS. 1821, SGR Reform, regarding all provisions.H.R. 4301, Protecting Access to Medicare act, regarding all provisions.

Client expense: $775,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R.1074/S.539 - National Diabetes Clinical Care Commission Act S.323/H.R. 1325/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013 H.R. 3710 - Medicare CGM Coverage Act

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1074/S.539 - National Diabetes Clinical Care Commission Act S.323/H.R. 1325/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013 H.R. 3710 - Medicare CGM Coverage Act

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 323/H.R. 1428 to extend immunosuppressive drug coverage in Medicare beyond the current three year cap; Encourage Congress to open Medicare Advantage to dialysis patients; H.R. 4814 to improve chronic kidney disease research and treatment; to remove proposed exemption in H.R. 4188 from dialysis patient readmission counting against hospital quality

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 1428/S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Advocating support for the Comprehensive Immunosuppressive Drug Coverage Act (S. 323/HR 1428).

Client expense: $16,902 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 323/H.R. 1428 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients; Urge Congress to stabilize dialysis reimbursement; Encourage Congress to open Medicare Advantage to dialysis patients.

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Response to proposed rule to amend protected class status of immunosuppressive drugs under Medicare Part D Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act; Blood Safety Issues

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1074/S.539 - National Diabetes Clinical Care Commission Act S.323/H.R. 1325/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013 S. 1871/H.R. 2810 - SGR Repeal and Medicare Beneficiary Access Act of 2013H.R. 1724 - Kids First Research Act of 2013 H.R. 2019 - Gabriella Miller Kids First Research Act S. 2000/H.R. 4015 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014 S. 2110 - Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 S. 2122 - Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 S. 2157 - Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 H.R. 4302 - Protecting Access to Medicare Act of 2014 H.R. 3710 - Medicare CGM Coverage Act

Client expense: $400,000 · Firm income: Not reported

Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 1428/S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act, chronic kidney disease, end-stage renal disease Medicare payment and quality; HR 2810 Medicare Patient Access and Quality Act of 2013, HR 4015, S. 2000, S. 2157, no billMedicare Physician payment Children's Hospitals Graduate Medical Education

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

S. 323/ H. R. 1428 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients; Ensuring Medicare ESRD Program is rebased in a way that does not negatively impact patients by protecting the integrity of the system, cautioning against rebasing too quickly and needing clarification from the FDA on ESA use.

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

P.L. 111-148/P.L. 111-152, Affordable Care Act, Health Care reform in general. H.R. 1428/S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Provision pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S.323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Provision pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S.323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provision pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S.323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provision pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S.323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advocated in support of transplant-related legislation HR 698/S330 and HR 1428/S323.

Client expense: $32,538 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1074/S.539 - National Diabetes Clinical Care Commission Act S.323/H.R. 1325/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013 S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013H.R. 1724 Kids First Research Act of 2013 H.R. 2019 Gabriella Miller Kids First Research Act

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Agency meeting to discuss (1) Physician Quality Reporting System and (2) Accountable Care Organizations

Client expense: $45,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

S. 323/H.R. 1428 Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients; Urge CMS to reverse decision to dramatically reduce funding for Medicare ESRD Program in rebasing process; Urge CMS to adopt additional patient protections in the Quality Incentive Program (QIP)

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

P.L.111-148/P.L.111-152, Affordable Care Act, Health care reform in general. H.R. 1428/S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. No Bill #, Legislation regarding Medicare physician payment, chronic kidney disease, end-stage renal disease Medicare payment and quality.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

S. 323/ H. R. 1428 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients; Urge CMS to reverse decision to dramatically reduce funding for Medicare ESRD Program in rebasing process; Urge CMS to adopt additional patient protections in the Quality Incentive Program (QIP).

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

HR 1325/S 323 -- Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act; Living Donor Registry; HR 698/S 330 HIV Organ Policy Equity Act ; Blood Safety Issues

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, Centers for Medicare and Medicaid Services reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. H.R. 8 American Taxpayer Relief Act; and S. 323/H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE